Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rebleeding after traumatic hyphema.

M A Thomas, R K Parrish, W J Feuer

    Archives of Ophthalmology (Chicago, Ill. : 1960)
    |February 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Fresh frozen plasma in postpartum hemorrhage: signal or severity?

    International journal of obstetric anesthesia·2026
    Same author

    51st annual meeting of ICBDSR: data that counts - transforming lives through birth defects surveillance.

    Journal of community genetics·2026
    Same author

    DNA methylation differences in monozygotic twins with Van der Woude syndrome.

    Frontiers in dental medicine·2023
    Same author

    Altered Blood Flow in the Ophthalmic and Internal Carotid Arteries in Patients with Age-Related Macular Degeneration Measured Using Noncontrast MR Angiography at 7T.

    AJNR. American journal of neuroradiology·2021
    Same author

    Magnetic Resonance Image-Guided Radiotherapy (MRIgRT): A 4.5-Year Clinical Experience.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2018
    Same author

    Steady-state PERG adaptation: a conspicuous component of response variability with clinical significance.

    Documenta ophthalmologica. Advances in ophthalmology·2018
    Same journal

    The economics of the initial preventive physical examination in medicare-reply.

    Archives of ophthalmology (Chicago, Ill. : 1960)·2013
    Same journal

    Modification of silicone oil retention sutures in aphakic eyes with iris loss-reply;.

    Archives of ophthalmology (Chicago, Ill. : 1960)·2013
    Same journal

    December 2011 archives web quiz winner.

    Archives of ophthalmology (Chicago, Ill. : 1960)·2013
    Same journal

    Angle involvement and glaucoma in patients with biopsy-proven iris melanoma: a response-reply.

    Archives of ophthalmology (Chicago, Ill. : 1960)·2013
    Same journal

    About this journal.

    Archives of ophthalmology (Chicago, Ill. : 1960)·2013
    Same journal

    In memoriam: goodwin m. Breinin, MD (1918-2011).

    Archives of ophthalmology (Chicago, Ill. : 1960)·2013
    See all related articles

    Traumatic hyphema rebleeding often necessitates surgery. Evaluating new treatments for hyphema requires considering rebleeding risks against general anesthesia complications.

    Area of Science:

    • Ophthalmology
    • Trauma Surgery

    Background:

    • Traumatic hyphema is a common ocular injury.
    • Rebleeding is a significant complication of traumatic hyphema.

    Purpose of the Study:

    • To determine the incidence of surgical intervention for rebleeding complications in traumatic hyphema patients.
    • To analyze surgical rates for primary and secondary hyphemas.

    Main Methods:

    • Retrospective review of 175 patients with traumatic hyphema admitted between 1977 and 1984.
    • Analysis of rebleeding rates and subsequent operative interventions.

    Main Results:

    • 16% of primary hyphema patients rebled during hospitalization, with 7 requiring surgery.
    • 32% of eyes that rebled underwent operative intervention.

    Related Experiment Videos

  • Surgery was rarely performed on eyes that did not rebleed.

    • Conclusions:

    • Rebleeding in traumatic hyphema frequently requires surgical intervention.
    • The risks of general anesthesia must be weighed against potential benefits of new treatments like epsilon-aminocaproic acid.